Lav Biosciences Fund V, L.P. has sold TERN and made no open-market buys since Nov 2022
10% owner at Terns Pharmaceuticals, Inc.
SEC CIK 0001764435 · Filings on SEC.gov ↗
$0Bought
$8.3MSold
NoneLast buy
Every filing
1 filing since Nov 2022, newest first
Filings come from SEC EDGAR. Not investment advice.